Summa Akron City Hospital, part of Summa Health System, was founded in 1892 in Akron, Ohio, United States. From the first accredited radiology department in the country to the first adult open heart surgery in Akron, Summa Akron City Hospital has achieved national recognition as a healthcare provider.

There are 680 beds in Akron City Hospital.

During the past decade, Akron City Hospital conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 69 clinical trials were completed, i.e. on average, 186.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 33 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Akron City Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 60 trials, followed by "National Cancer Institute (NCI)" with 55 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "NSABP Foundation Inc" with 12 trials sponsored and "GOG Foundation" with 12 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Akron City Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 112 trials as a collaborator, "NRG Oncology" with 36 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "North Central Cancer Treatment Group" with 8 trials as a collaborator and "Eastern Cooperative Oncology Group" with 7 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Akron City Hospital" are "Breast Cancer" (17 trials), "Head and Neck Cancer" (14 trials), "Lung Cancer" (12 trials), "Prostate Cancer" (12 trials) and "Brain and Central Nervous System Tumors" (8 trials). Many other conditions were trialed in "Akron City Hospital" in a lesser frequency.

Most popular intervention types in "Akron City Hospital" are "Drug" (148 trials), "Radiation" (87 trials), "Other" (71 trials), "Biological" (61 trials) and "Procedure" (44 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (45 trials), "Quality-of-Life Assessment" (39 trials), "Laboratory Biomarker Analysis" (38 trials), "Paclitaxel" (29 trials) and "Carboplatin" (24 trials). Other intervention names were less common.

The vast majority of trials in "Akron City Hospital" are 123 trials for "All" genders, 50 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Akron City Hospital". undefined are not yet recruiting, 13 are recruiting, 60 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 101 completed trials in Akron City Hospital, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Akron City Hospital, 13 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 112 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".

Akron City Hospital has several departments that took part in Clinical trials: "Summa Center for Cancer Care at Akron City Hospital" - 141 trials, "Summa Center for Clinical Trials-Northeast Ohio Cardiovascular Specialists" - 3 trials